Bristol Myers Squibb (BMY) Tax Rate (2009 - 2026)
Bristol Myers Squibb's (BMY) quarterly Tax Rate came in at 18.84% in Q2 2026, down 710.0% year-over-year from 3.09% in Q2 2025, and up 8.84% quarter-over-quarter from 17.31% in Q1 2026.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Tax Rate (2009 - 2026) Analysis & Trends
Bristol Myers Squibb (BMY) has reported Tax Rate for 18 consecutive years, with 18.84% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Rate fell 710.0% year-over-year to 18.84% in Q2 2026; TTM through Jun 2026 was 22.12%, a 107.0% decrease from a year earlier, with the FY2025 full-year figure at 24.36%, up 3097.0% from the prior year.
- Tax Rate was 18.84% for Q2 2026 at Bristol Myers Squibb, up from 17.31% in the prior quarter.
- Over five years, Tax Rate peaked at 56.57% in Q4 2024 and troughed at 30.95% in Q2 2024.
- A 5-year average of 14.7% and a median of 18.5% in 2026 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate slumped 3874 bps in 2023 and surged 6183 bps in 2024, its largest moves.
- Over 5 years, Tax Rate stood at 8.93% in 2022, then soared by 41 bps to 5.26% in 2023, then soared by 1176 bps to 56.57% in 2024, then slumped by 54 bps to 26.12% in 2025, then decreased by 28 bps to 18.84% in 2026.
- The last three Tax Rate figures came in at 18.84% (Q2 2026), 17.31% (Q1 2026), and 26.12% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 62.33% |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 18.84% |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -31.96% |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 24.15% |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 22.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.84% |
| Mar 31, 2026 | 17.31% |
| Dec 31, 2025 | 26.12% |
| Sep 30, 2025 | 29.51% |
| Jun 30, 2025 | 25.94% |
| Mar 31, 2025 | 17.13% |
| Dec 31, 2024 | 56.57% |
| Sep 30, 2024 | 27.51% |
| Jun 30, 2024 | -30.95% |
| Mar 31, 2024 | -3.40% |
| Dec 31, 2023 | -5.26% |
| Sep 30, 2023 | 9.50% |
| Jun 30, 2023 | -11.73% |
| Mar 31, 2023 | 18.16% |
| Dec 31, 2022 | -8.93% |
| Sep 30, 2022 | 27.21% |
| Jun 30, 2022 | 27.02% |
| Mar 31, 2022 | 23.95% |
| Dec 31, 2021 | -27.66% |
| Sep 30, 2021 | 28.05% |